Suppr超能文献

巴西肝癌景观。

Brazilian Landscape of Hepatocellular Carcinoma.

机构信息

Medical Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, University of São Paulo, School of Medicine, São Paulo, Brazil.

Department of Radiation Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, University of São Paulo, School of Medicine, São Paulo, Brazil.

出版信息

JCO Glob Oncol. 2023 Jun;9:e2200416. doi: 10.1200/GO.22.00416.

Abstract

The incidence of hepatocellular carcinoma (HCC) is expected to increase in the coming years, and strategies to mitigate the burden of this disease are needed in different regions. Geographic variations in epidemiology and risk factors, such as viral hepatitis and metabolic disease, pose challenges in adopting programs for early detection programs and management of patients with HCC. Brazil, like other countries, has high economic and social inequality, with heterogeneous access to health care. Viral hepatitis is the main risk factor but there is growing awareness of fatty liver disease. Risk factor monitoring and screening programs are unmet priorities because patients are often diagnosed at later stages. Advances in the management of patients with HCC have been made in recent years, including new tools for selecting patients for liver transplantation, sophisticated surgical techniques, and new systemic agents. High-volume academic centers often achieve favorable results through the adoption and application of established treatments, but this is not a reality in most regions of Brazil, because of disparities in wealth and resources. As HCC management requires a coordinated and multidisciplinary team, the role of local referral centers in decentralizing access to treatments and promoting health education in different regions should be encouraged and supported.

摘要

肝细胞癌(HCC)的发病率预计在未来几年将会增加,因此需要在不同地区制定减轻这一疾病负担的策略。流行病学和风险因素(如病毒性肝炎和代谢性疾病)的地理差异给采用早期检测计划和 HCC 患者管理方案带来了挑战。巴西与其他国家一样,存在着巨大的经济和社会不平等,在获得医疗保健方面存在差异。病毒性肝炎是主要的风险因素,但人们对脂肪肝疾病的认识正在不断提高。由于患者通常处于晚期诊断,因此风险因素监测和筛查计划仍是未得到满足的优先事项。近年来,HCC 患者的管理取得了一些进展,包括用于选择肝移植患者的新工具、复杂的手术技术和新的系统药物。高容量学术中心经常通过采用和应用既定的治疗方法来取得良好的效果,但在巴西的大多数地区,由于财富和资源的差异,这并不是现实。由于 HCC 管理需要协调和多学科团队,因此应鼓励和支持当地转诊中心在不同地区分散治疗途径并促进健康教育方面发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f239/10497258/ebbeab84d0ef/go-9-e2200416-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验